Today we present 29 new placebo and nocebo research papers, comments and abstracts identified during June 2020. As usual, they are based on new PUBMED publication using the search terms „placebo“ and „nocebo“ and are hand-selected from more than 803 new publications during the preceding month. Previously published monthly updates can be found in our archive. Todays selection as well as all previously identified papers will also go into our placebo research library that currently contains more than 4,500 relevant papers. If you would like to get access to the full database, please register for our newsletter and provide us with your email address and affiliation.
Anderson, S., & Stebbins, G. T. (2020).
Determinants of placebo effects. Int Rev Neurobiol, 153, 27-47. doi:10.1016/bs.irn.2020.03.029
https://www.ncbi.nlm.nih.gov/pubmed/32563291
Annoni, M. (2020).
Better than nothing: A historical account of placebos and placebo effects from modern to contemporary medicine. Int Rev Neurobiol, 153, 3-26. doi:10.1016/bs.irn.2020.03.028
https://www.ncbi.nlm.nih.gov/pubmed/32563292
Aujla, R. S., Agarwal, R., Sinha, S., & Kumar, A. (2020).
Perception and practice of placebo use among physicians in Mangalore. J Family Med Prim Care, 9(3), 1424-1430. doi:10.4103/jfmpc.jfmpc_1052_19
https://www.ncbi.nlm.nih.gov/pubmed/32509627
Bernstein, M. H., Locher, C., Stewart-Ferrer, S., Buergler, S., DesRoches, C. M., Dossett, M. L., Miller, F. G., Grose, D., & Blease, C. R. (2020).
Primary care providers’ use of and attitudes towards placebos: An exploratory focus group study with US physicians. Br J Health Psychol. doi:10.1111/bjhp.12429
https://www.ncbi.nlm.nih.gov/pubmed/32472982
Borissova, A., Ferguson, B., Wall, M. B., Morgan, C. J., Carhart-Harris, R. L., Bolstridge, M., Bloomfield, M. A., Williams, T. M., Feilding, A., Murphy, K., Tyacke, R. J., Erritzoe, D., Stewart, L., Wolff, K., Nutt, D., Curran, H. V., & Lawn, W. (2020).
Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment. J Psychopharmacol, 269881120926673. doi:10.1177/0269881120926673
https://www.ncbi.nlm.nih.gov/pubmed/32538252
Colloca, L. (2020).
Placebo effects in pain. Int Rev Neurobiol, 153, 167-185. doi:10.1016/bs.irn.2020.04.001
https://www.ncbi.nlm.nih.gov/pubmed/32563287
Colloca, L., Akintola, T., Haycock, N. R., Blasini, M., Thomas, S., Phillips, J., Corsi, N., Schenk, L. A., & Wang, Y. (2020).
Prior Therapeutic Experiences, Not Expectation Ratings, Predict Placebo Effects: An Experimental Study in Chronic Pain and Healthy Participants. Psychother Psychosom, 1-8. doi:10.1159/000507400
https://www.ncbi.nlm.nih.gov/pubmed/32492688
Duale, C., Macian, N., Giron, F., & Pickering, G. (2020).
Non-specific analgesia during a clinical trial in fibromyalgia. Eur J Clin Invest, e13337. doi:10.1111/eci.13337
https://www.ncbi.nlm.nih.gov/pubmed/32585738
Gillving, M., Demant, D., Lund, K., Holbech, J. V., Otto, M., Vase, L., Jensen, T. S., Bach, F. W., Finnerup, N. B., & Sindrup, S. H. (2020).
Factors with impact on magnitude of the placebo response in randomized, controlled, cross-over trials in peripheral neuropathic pain. doi:10.1097/j.pain.0000000000001964
https://www.ncbi.nlm.nih.gov/pubmed/32569087
Goldenholz, D. M., & Goldenholz, S. R. (2020).
Placebo in epilepsy. Int Rev Neurobiol, 153, 231-266. doi:10.1016/bs.irn.2020.03.033
https://www.ncbi.nlm.nih.gov/pubmed/32563290
Goldstein, P., Losin, E. A. R., Anderson, S. R., Schelkun, V. R., & Wager, T. D. (2020).
Clinician-patient movement synchrony mediates social group effects on interpersonal trust and perceived pain. J Pain. doi:10.1016/j.jpain.2020.03.001
https://www.ncbi.nlm.nih.gov/pubmed/32544602
Ito, K., & Romero, K. (2020).
Placebo effect in subjects with cognitive impairment. Int Rev Neurobiol, 153, 213-230. doi:10.1016/bs.irn.2020.03.032
https://www.ncbi.nlm.nih.gov/pubmed/32563289
Karahalios, A., Herbison, G. P., & McKenzie, J. E. (2020).
Placebo run-in periods in anticholinergic trials are not associated with treatment effect size or risk of attrition: an empirical evaluation. J Clin Epidemiol. doi:10.1016/j.jclinepi.2020.05.032
https://www.ncbi.nlm.nih.gov/pubmed/32531264
Kravvariti, E., Kitas, G. D., & Sfikakis, P. P. (2019).
The role of the Nocebo effect in the use of biosimilars in routine rheumatology clinical practice. Mediterr J Rheumatol, 30(Suppl 1), 63-68. doi:10.31138/mjr.30.1.63
https://www.ncbi.nlm.nih.gov/pubmed/32524080
Lara, L. A. S. (2020).
Pharmacological treatment of female sexual dysfunction: a critical analysis of the placebo and nocebo effects. Einstein, 18, eED5616. doi:10.31744/einstein_journal/2020ED5616
https://www.ncbi.nlm.nih.gov/pubmed/32578685
Lou, J. S. (2020).
Placebo responses in Parkinson’s disease. Int Rev Neurobiol, 153, 187-211. doi:10.1016/bs.irn.2020.03.031
https://www.ncbi.nlm.nih.gov/pubmed/32563288
MacFarlane, D., Hurlstone, M. J., & Ecker, U. K. H. (2020).
Countering demand for ineffective health remedies: Do consumers respond to risks, lack of benefits, or both? Psychol Health, 1-19. doi:10.1080/08870446.2020.1774056
https://www.ncbi.nlm.nih.gov/pubmed/32508141
MacKrill, K., Gamble, G. D., & Petrie, K. (2020).
The Effect of Television and Print News Stories on the Nocebo Responding Following a Generic Medication Switch. Clinical Psychology in Europe, 2(2). doi:10.32872/cpe.v2i2.2623
https://doi.org/10.32872/cpe.v2i2.2623
Mariani, L. L., & Corvol, J. C. (2020).
Maximizing placebo response in neurological clinical practice. Int Rev Neurobiol, 153, 71-101. doi:10.1016/bs.irn.2020.04.003
https://www.ncbi.nlm.nih.gov/pubmed/32563294
Masurovsky, A. (2020).
Controlling for Placebo Effects in Computerized Cognitive Training Studies With Healthy Older Adults From 2016-2018: Systematic Review. JMIR Serious Games, 8(2), e14030. doi:10.2196/14030
https://www.ncbi.nlm.nih.gov/pubmed/32589159
Parker, G., Ricciardi, T., & Hadzi-Pavlovic, D. (2020).
Placebo response rates in trials of antidepressant drugs in adults with clinical depression: Increasing, decreasing, constant or all of the above? J Affect Disord, 271, 139-144. doi:10.1016/j.jad.2020.03.065
https://www.ncbi.nlm.nih.gov/pubmed/32479309
Raman, R. (2020).
Statistical methods in handling placebo effect. Int Rev Neurobiol, 153, 103-120. doi:10.1016/bs.irn.2020.04.004
https://www.ncbi.nlm.nih.gov/pubmed/32563284
Rodrigues, F. B., & Ferreira, J. J. (2020).
Strategies to minimize placebo effects in research investigations. Int Rev Neurobiol, 153, 49-70. doi:10.1016/bs.irn.2020.04.002
https://www.ncbi.nlm.nih.gov/pubmed/32563293
Roelands, B., & Hurst, P. (2020).
The Placebo Effect in Sport: How Practitioners Can Inject Words to Improve Performance. Int J Sports Physiol Perform, 1-2. doi:10.1123/ijspp.2020-0358
https://www.ncbi.nlm.nih.gov/pubmed/32492654
Rossettini, G., Camerone, E. M., Carlino, E., Benedetti, F., & Testa, M. (2020).
Context matters: the psychoneurobiological determinants of placebo, nocebo and context-related effects in physiotherapy. Arch Physiother, 10, 11. doi:10.1186/s40945-020-00082-y
https://www.ncbi.nlm.nih.gov/pubmed/32537245
Seftel, A. D. (2020).
Re: Placebo Responses among Men with Erectile Dysfunction Enrolled in Phosphodiesterase 5 Inhibitor Trials: A Systematic Review and Meta-Analysis. J Urol. doi:10.1097/JU.0000000000001167.02
https://www.ncbi.nlm.nih.gov/pubmed/32586193
Stoessl, A. J. (2020).
Deception and the ethics of placebo. Int Rev Neurobiol, 153, 147-163. doi:10.1016/bs.irn.2020.03.030
https://www.ncbi.nlm.nih.gov/pubmed/32563286
Mestre, T. A. (2020).
Nocebo and lessebo effects. Int Rev Neurobiol, 153, 121-146. doi:10.1016/bs.irn.2020.04.005
https://www.ncbi.nlm.nih.gov/pubmed/32563285
Wagner, I. C., Rutgen, M., Hummer, A., Windischberger, C., & Lamm, C. (2020).
Placebo-induced pain reduction is associated with negative coupling between brain networks at rest. Neuroimage, 219, 117024. doi:10.1016/j.neuroimage.2020.117024
https://www.ncbi.nlm.nih.gov/pubmed/32512124